| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| NM_013302.3 | .a | 1 to 7412 | 1 to 7412 | Q361R | RefSeq, | 7412/7412 (100 %) | 1 diff (100.0 %id) | ||
| BP281026 | .a | 12 to 598 | 1 to 587 | tiling clone, | 587/587 (100 %) | 1 diff (99.9 %id) | |||
| BP283664 | bone marrow | .a | 12 to 602 | 1 to 592 | 592/592 (100 %) | 4 diff (99.4 %id) | |||
| DA995170 | synovial membrane tissue from rheumatioidarthritis | .a | 13 to 558 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | ||
| DA869123 | Prostate | .a | 18 to 559 | 2 to 543 | capped | 542/542 (100 %) | 1 diff (99.9 %id) | ||
| DB479711 | hippocampus | .a | 22 to 276 | 1 to 255 | 255/255 (100 %) | 1 diff (99.7 %id) | |||
| BM008487 | Spleen | .a | 24 to 834 | 1 to 806 | 804/828 (97 %) | 14 diff (98.4 %id) | |||
| TI_59383220 | .a | 25 to 834 | 109 to 913 | 803/827 (97 %) | 13 diff (98.5 %id) | ||||
| CN412117 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 44 to 519 | 1 to 476 | 476/476 (100 %) | 0 diff (100 %id) | |||
| DB139464 | thymus | .a | 45 to 587 | 2 to 544 | capped | 543/543 (100 %) | 0 diff (100 %id) | ||
| DA186148 | amygdala | .a | 57 to 581 | 2 to 526 | capped | 525/525 (100 %) | 0 diff (100 %id) | ||
| DA187710 | amygdala | .a | 57 to 594 | 2 to 540 | capped | 539/539 (100 %) | 1 diff (99.9 %id) | ||
| BU173085 | eye, retinoblastoma | .a | 63 to 407 | 1 to 348 | 348/957 (36 %) | 4 diff (99.6 %id) | |||
| DN997421 | breast cancer, Mammary gland (cancer tissue) | .a | 67 to 631 | 9 to 573 | 565/573 (98 %) | 0 diff (100 %id) | |||
| CV572706 | cornea, eye | .a | 68 to 690 | 1 to 623 | 623/623 (100 %) | 0 diff (100 %id) | |||
| DA556486 | .a | 105 to 656 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | |||
| CD624721 | .a | 347 to 1065 | 8 to 727 | 720/743 (96 %) | 11 diff (98.6 %id) | ||||
| CD624722 | .a | 347 to 1065 | 732 to 15 | 718/746 (96 %) | 2 diff (99.8 %id) | ||||
| BP313834 | mammary gland | .a | 414 to 995 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
| AU099108 | .a | 428 to 728 | 1 to 300 | 300/300 (100 %) | 5 diff (98.4 %id) | ||||
| AU104251 | .a | 428 to 477 | 1 to 50 | 50/50 (100 %) | 1 diff (98.0 %id) | ||||
| TI_1948086965 | .a | 485 to 1388 | 125 to 1037 | 911/1191 (76 %) | 30 diff (97.5 %id) | ||||
| TI_1948087109 | .a | 485 to 1235 | 133 to 896 | 764/1280 (59 %) | 33 diff (97.5 %id) | ||||
| TI_1948087257 | .a | 485 to 1388 | 131 to 1035 | 905/1172 (77 %) | 21 diff (98.3 %id) | ||||
| TI_1948087407 | .a | 485 to 1254 | 125 to 899 | 775/1248 (62 %) | 17 diff (98.7 %id) | ||||
| CV030771 | mixed | .a | 486 to 1164 | 1 to 679 | 679/682 (99 %) | 6 diff (99.2 %id) | |||
| U93850 | .a | 486 to 2663 | 1 to 2178 | Q361R | tiling clone, | 2178/2178 (100 %) | 7 diff (99.7 %id) | ||
| AW672668 | cervix | .a | 561 to 777 | 1 to 220 | 220/222 (99 %) | 4 diff (98.2 %id) | |||
| BG107320 | lymph, lymphoma, cell line | .a | 915 to 1674 | 1 to 751 | 753/886 (84 %) | 19 diff (97.9 %id) | |||
| CA397138 | eye, RPE/choroid | .a | 1091 to 1662 | 1 to 572 | tiling clone, | 572/572 (100 %) | 1 diff (99.9 %id) | ||
| BF951832 | nervous_normal | .a | 1184 to 1678 | 508 to 15 | 494/508 (97 %) | 0 diff (100 %id) | |||
| BF951953 | nervous_normal | .a | 1253 to 1678 | 438 to 14 | 425/438 (97 %) | 0 diff (100 %id) | |||
| T84514 | liver and spleen | .a | 1377 to 1716 | 1 to 347 | 347/358 (96 %) | 17 diff (95.3 %id) | |||
| CR747369 | leiomyosarcoma, uterus | .a | 1466 to 1946 | 24 to 504 | 481/504 (95 %) | 7 diff (98.7 %id) | |||
| BQ432467 | leiomyosarcoma, uterus | .a | 1466 to 2258 | 12 to 814 | 803/907 (88 %) | 25 diff (97.3 %id) | |||
| CU443520 | epidermis | .a | 1553 to 2012 | 59 to 519 | 461/521 (88 %) | 7 diff (98.7 %id) | |||
| BF751111 | breast_normal | .a | 1796 to 2208 | 425 to 13 | Submitted on the opposite strand | 413/433 (95 %) | 1 diff (99.8 %id) | ||
| TI_1948087408 | .a | 1917 to 2666 | 874 to 121 | 754/1244 (60 %) | 22 diff (98.3 %id) | ||||
| TI_1948087258 | .a | 1927 to 2666 | 864 to 123 | 742/1269 (58 %) | 8 diff (99.4 %id) | ||||
| TI_1948086966 | .a | 1929 to 2665 | 866 to 126 | 741/1262 (58 %) | 8 diff (99.4 %id) | ||||
| TI_1948087110 | .a | 1978 to 2666 | 806 to 108 | 699/1353 (51 %) | 18 diff (98.7 %id) | ||||
| CU454899 | epidermis | .a | 2133 to 2675 | 549 to 7 | Submitted on the opposite strand | 543/574 (94 %) | 2 diff (99.7 %id) | ||
| BE931888 | head_neck | .a | 2150 to 2356 | 216 to 10 | 207/231 (89 %) | 0 diff (100 %id) | |||
| AW675420 | cervix | .a | 2265 to 2817 | 553 to 1 | tiling clone, | 553/553 (100 %) | 0 diff (100 %id) | ||
| BF447300 | Prostate | .a | 2313 to 2532 | 299 to 80 | AAA | 220/288 (76 %) | 6 diff (98.0 %id) | ||
| AU185849 | skin | .a | 2441 to 2708 | 268 to 1 | 268/268 (100 %) | 0 diff (100 %id) | |||
| AK022569 | .a | 2510 to 5297 | 1 to 2786 | tiling clone, available from FLJ, | 2786/2786 (100 %) | 10 diff (99.7 %id) | |||
| AU124127 | .a | 2511 to 3253 | 2 to 743 | capped | 742/742 (100 %) | 3 diff (99.6 %id) | |||
| DA644025 | .a | 2655 to 3204 | 2 to 552 | capped | 551/551 (100 %) | 2 diff (99.7 %id) | |||
| AA988161 | carcinoid, lung | .a | 2713 to 2977 | 280 to 16 | 265/280 (94 %) | 0 diff (100 %id) | |||
| DB206192 | trachea | .a | 2741 to 3317 | 2 to 579 | capped | 578/578 (100 %) | 3 diff (99.5 %id) | ||
| DA387216 | thalamus | .a | 2804 to 3404 | 2 to 601 | tiling clone, capped | 600/600 (100 %) | 1 diff (99.9 %id) | ||
| BM015136 | breast, mammary adenocarcinoma, cell line | .a | 2821 to 3624 | 1 to 791 | 791/791 (100 %) | 27 diff (96.6 %id) | |||
| TI_59393257 | .a | 2821 to 3624 | 84 to 874 | 791/791 (100 %) | 27 diff (96.6 %id) | ||||
| BQ222242 | melanotic melanoma, skin | .a | 2843 to 3652 | 11 to 834 | 824/900 (91 %) | 16 diff (98.3 %id) | |||
| BX425225 | neuroblastoma | .a | 3099 to 4147 | 1 to 1039 | 1039/1100 (94 %) | 7 diff (99.4 %id) | |||
| DA089718 | cerebellum | .a | 3271 to 3757 | 2 to 488 | capped | 487/487 (100 %) | 1 diff (99.8 %id) | ||
| BM462945 | melanotic melanoma, skin | .a | 3278 to 3948 | 54 to 730 | 677/1064 (63 %) | 9 diff (99.2 %id) | |||
| DA945100 | Spleen | .a | 3278 to 3813 | 2 to 537 | capped | 536/536 (100 %) | 2 diff (99.7 %id) | ||
| CN294961 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 3281 to 3899 | 1 to 619 | tiling clone, | 619/619 (100 %) | 0 diff (100 %id) | ||
| DA237456 | brain | .a | 3292 to 3857 | 2 to 568 | capped | 567/567 (100 %) | 1 diff (99.9 %id) | ||
| CN290312 | embryonic stem cells, DMSO-treated H9 cellline | .a | 3340 to 4023 | 1 to 684 | 684/684 (100 %) | 0 diff (100 %id) | |||
| BQ881089 | epidermoid carcinoma, cell line, salivary gland | .a | 3377 to 4100 | 1 to 728 | 728/921 (79 %) | 12 diff (98.7 %id) | |||
| BQ671518 | epidermoid carcinoma, cell line, salivary gland | .a | 3377 to 4191 | 1 to 815 | 815/928 (87 %) | 1 diff (99.9 %id) | |||
| BQ672427 | epidermoid carcinoma, cell line, salivary gland | .a | 3377 to 4181 | 1 to 812 | 812/917 (88 %) | 15 diff (98.4 %id) | |||
| BG249082 | hypernephroma, cell line, Kidney | .a | 3452 to 4213 | 1 to 754 | 754/947 (79 %) | 24 diff (97.5 %id) | |||
| AW752801 | colon | .a | 3473 to 4014 | 1 to 542 | 542/542 (100 %) | 1 diff (99.9 %id) | |||
| AA324198 | brain | .a | 3477 to 3893 | 1 to 417 | 417/417 (100 %) | 0 diff (100 %id) | |||
| BF982299 | duodenal adenocarcinoma, cell line, small intestine | .a | 3477 to 4166 | 1 to 688 | 688/923 (74 %) | 9 diff (99.1 %id) | |||
| BF982428 | duodenal adenocarcinoma, cell line, small intestine | .a | 3477 to 4255 | 1 to 779 | 779/1086 (71 %) | 30 diff (97.3 %id) | |||
| CV569264 | cornea, eye | .a | 3506 to 4117 | 1 to 612 | 612/612 (100 %) | 0 diff (100 %id) | |||
| CD515600 | White Matter | .a | 3519 to 4378 | 869 to 1 | Submitted on the opposite strand | 869/882 (98 %) | 7 diff (99.3 %id) | ||
| AI910073 | breast | .a | 3524 to 4014 | 492 to 1 | 492/492 (100 %) | 4 diff (99.2 %id) | |||
| BE799747 | lung, small cell carcinoma | .a | 3533 to 4296 | 44 to 802 | 759/1049 (72 %) | 18 diff (98.3 %id) | |||
| CV569307 | cornea, eye | .a | 3543 to 3700 | 1 to 159 | 159/159 (100 %) | 8 diff (95.0 %id) | |||
| AW900346 | nervous_normal | .a | 3575 to 3835 | 10 to 269 | 260/272 (95 %) | 5 diff (98.2 %id) | |||
| DA104569 | cerebellum | .a | 3615 to 4168 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
| CD105917 | brain, Pituitary | .a | 3692 to 4219 | 1 to 530 | 530/534 (99 %) | 6 diff (98.9 %id) | |||
| CB409848 | maxilla, pooled | .a | 4015 to 4461 | 1 to 447 | 447/447 (100 %) | 5 diff (98.9 %id) | |||
| BE262429 | brain, neuroblastoma | .a | 4043 to 4823 | 22 to 804 | 783/1003 (78 %) | 23 diff (97.8 %id) | |||
| BG984541 | colon_normal | .a | 4063 to 4507 | 455 to 11 | 445/455 (97 %) | 0 diff (100 %id) | |||
| CR621051 | Placenta Cot 25-normalized | .a | 4087 to 5280 | 1 to 1194 | 1194/1194 (100 %) | 0 diff (100 %id) | |||
| BX398306 | Placenta Cot 25-normalized | .a | 4087 to 5175 | 1 to 1084 | 1084/1084 (100 %) | 11 diff (99.0 %id) | |||
| CA866416 | Pancreas, Purified pancreatic islet | .a | 4175 to 4717 | 10 to 552 | 543/552 (98 %) | 6 diff (99.0 %id) | |||
| BQ671287 | epidermoid carcinoma, cell line, salivary gland | .a | 4257 to 5078 | 23 to 845 | 823/1018 (80 %) | 19 diff (98.2 %id) | |||
| T95767 | liver and spleen | .a | 4348 to 4772 | 1 to 438 | 438/450 (97 %) | 17 diff (96.3 %id) | |||
| BM769317 | stomach | .a | 4367 to 4832 | 1 to 466 | 466/466 (100 %) | 0 diff (100 %id) | |||
| BQ084067 | stomach | .a | 4367 to 4693 | 1 to 327 | 327/327 (100 %) | 1 diff (99.7 %id) | |||
| BX372064 | .a | 4383 to 5311 | 919 to 1 | 919/921 (99 %) | 34 diff (96.4 %id) | ||||
| TI_154159545 | .a | 4386 to 5039 | 95 to 747 | 653/662 (98 %) | 9 diff (98.7 %id) | ||||
| AW503611 | lymph | .a | 4388 to 4962 | 10 to 584 | 575/584 (98 %) | 6 diff (99.0 %id) | |||
| BU150593 | dorsal root ganglia | .a | 4465 to 5231 | 1 to 771 | 771/778 (99 %) | 10 diff (98.8 %id) | |||
| CB162483 | Liver | .a | 4489 to 5027 | 37 to 578 | 542/578 (93 %) | 6 diff (99.0 %id) | |||
| DA447732 | tongue, tumor tissue | .a | 4511 to 5061 | 2 to 552 | capped | 551/551 (100 %) | 1 diff (99.9 %id) | ||
| AI868762 | pooled | .a | 4529 to 4829 | 1 to 302 | Submitted on the opposite strand | 302/312 (96 %) | 1 diff (99.7 %id) | ||
| BF108667 | pooled | .a | 4529 to 5029 | 1 to 501 | Submitted on the opposite strand | 501/501 (100 %) | 0 diff (100 %id) | ||
| AI858107 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .a | 4544 to 5031 | 21 to 508 | AAA | Submitted on the opposite strand | 488/508 (96 %) | 6 diff (98.9 %id) | |
| TI_158431018 | .a | 4549 to 5297 | 856 to 101 | AAA | 756/878 (86 %) | 26 diff (97.1 %id) | |||
| CB050995 | Prostate | .a | 4555 to 4651 | 10 to 106 | 97/106 (91 %) | 6 diff (94.4 %id) | |||
| BE783000 | eye, retinoblastoma | .a | 4572 to 5254 | 1 to 685 | 685/789 (86 %) | 25 diff (96.9 %id) | |||
| TI_149312981 | .a | 4573 to 5297 | 813 to 89 | AAA | 725/941 (77 %) | 13 diff (98.7 %id) | |||
| BQ771915 | Chondrosarcoma Grade II, Left Pelvis | .a | 4612 to 5297 | 704 to 19 | AAA | 686/686 (100 %) | 1 diff (99.9 %id) | ||
| AW851752 | colon | .a | 4631 to 4785 | 1 to 155 | 155/157 (98 %) | 3 diff (98.1 %id) | |||
| AA349608 | brain | .a | 4644 to 4993 | 351 to 1 | 351/351 (100 %) | 1 diff (99.8 %id) | |||
| BF911979 | uterus_tumor | .a | 4698 to 5038 | 365 to 25 | Submitted on the opposite strand | 341/365 (93 %) | 0 diff (100 %id) | ||
| CB409847 | maxilla, pooled | .a | 4709 to 5297 | 632 to 44 | AAA | 589/589 (100 %) | 1 diff (99.9 %id) | ||
| AA152339 | colon, tumor | .a | 4717 to 5002 | 1 to 300 | fully sequenced, | 300/300 (100 %) | 1 diff (99.7 %id) | ||
| CB050994 | Prostate | .a | 4719 to 5294 | 599 to 24 | AAA | 576/576 (100 %) | 3 diff (99.5 %id) | ||
| CF528464 | placenta | .a | 4720 to 5297 | 593 to 16 | AAA | 578/578 (100 %) | 0 diff (100 %id) | ||
| BU784178 | insulinoma, Pancreas | .a | 4732 to 5304 | 8 to 580 | 573/580 (98 %) | 6 diff (99.0 %id) | |||
| T86802 | liver and spleen | .a | 4745 to 5212 | 1 to 478 | 478/478 (100 %) | 16 diff (96.7 %id) | |||
| CF541054 | lung | .a | 4783 to 5297 | 531 to 17 | AAA | 515/515 (100 %) | 0 diff (100 %id) | ||
| AI655968 | pooled germ cell tumors | .a | 4784 to 5297 | 514 to 1 | 514/514 (100 %) | 1 diff (99.9 %id) | |||
| BF001312 | Prostate | .a | 4784 to 5297 | 514 to 1 | 514/514 (100 %) | 0 diff (100 %id) | |||
| AA748060 | germinal center B cell | .a | 4795 to 5300 | 507 to 3 | 505/507 (99 %) | 0 diff (100 %id) | |||
| BQ012225 | placenta | .a | 4797 to 5297 | 517 to 17 | AAA | 501/501 (100 %) | 0 diff (100 %id) | ||
| AW173696 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 4798 to 5300 | 503 to 1 | 503/503 (100 %) | 0 diff (100 %id) | |||
| AA744627 | germinal center B cell | .a | 4802 to 5239 | 438 to 1 | 438/438 (100 %) | 0 diff (100 %id) | |||
| AA262907 | germinal center B cell | .a | 4815 to 5019 | 1 to 203 | 203/203 (100 %) | 4 diff (98.1 %id) | |||
| DA086214 | cerebellum | .a | 4823 to 5286 | 2 to 465 | capped | 464/464 (100 %) | 0 diff (100 %id) | ||
| H98760 | melanocyte | .a | 4823 to 5297 | 476 to 1 | 476/476 (100 %) | 1 diff (99.8 %id) | |||
| AI087877 | pooled | .a | 4839 to 5341 | 513 to 11 | AAA | 503/503 (100 %) | 0 diff (100 %id) | ||
| BF342148 | brain, glioblastoma with EGFR amplification | .a | 4842 to 5522 | 1 to 672 | 672/678 (99 %) | 14 diff (98.0 %id) | |||
| AL702876 | human skeletal muscle | .a | 4846 to 5429 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
| T95768 | liver and spleen | .a | 4864 to 5294 | 435 to 1 | 435/437 (99 %) | 7 diff (98.4 %id) | |||
| AI041583 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 4864 to 5298 | 435 to 1 | 435/435 (100 %) | 0 diff (100 %id) | |||
| AI149514 | placenta | .a | 4864 to 5300 | 437 to 1 | 437/437 (100 %) | 0 diff (100 %id) | |||
| H95370 | placenta | .a | 4865 to 5278 | 414 to 1 | 414/419 (98 %) | 1 diff (99.8 %id) | |||
| BM738006 | Ascites, stomach | .a | 4910 to 5294 | 1 to 383 | AAA | 383/383 (100 %) | 4 diff (99.0 %id) | ||
| CB267563 | adipose | .a | 4926 to 5626 | 1 to 700 | 700/700 (100 %) | 7 diff (99.0 %id) | |||
| BX641681 | .a | 4930 to 5300 | 381 to 11 | Submitted on the opposite strand | 371/381 (97 %) | 0 diff (100 %id) | |||
| AI453505 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .a | 4933 to 5297 | 381 to 17 | AAA | 365/365 (100 %) | 1 diff (99.8 %id) | ||
| AW661897 | colon, moderately-differentiated adenocarcinoma | .a | 4941 to 5297 | 357 to 1 | 357/357 (100 %) | 0 diff (100 %id) | |||
| AI992280 | anaplastic oligodendroglioma, brain | .a | 4953 to 5297 | 364 to 20 | AAA | 345/345 (100 %) | 3 diff (99.2 %id) | ||
| BG057770 | dorsal root ganglia | .a | 4955 to 5300 | 346 to 1 | 346/346 (100 %) | 0 diff (100 %id) | |||
| AA152340 | colon, tumor | .a | 4972 to 5269 | 304 to 1 | fully sequenced, | 304/304 (100 %) | 1 diff (99.7 %id) | ||
| CU443970 | epidermis | .a | 4995 to 5534 | 1 to 540 | 540/575 (93 %) | 8 diff (98.7 %id) | |||
| CU444819 | epidermis | .a | 4995 to 5534 | 1 to 540 | tiling clone, | 540/555 (97 %) | 7 diff (98.8 %id) | ||
| CU445692 | epidermis | .a | 4995 to 5534 | 1 to 540 | 540/555 (97 %) | 8 diff (98.6 %id) | |||
| CU447170 | epidermis | .a | 4995 to 5605 | 1 to 611 | 611/626 (97 %) | 8 diff (98.8 %id) | |||
| CU447703 | epidermis | .a | 4995 to 5534 | 1 to 540 | 540/555 (97 %) | 9 diff (98.4 %id) | |||
| AI658638 | Prostate | .a | 5001 to 5297 | 323 to 27 | AAA | 297/297 (100 %) | 5 diff (98.4 %id) | ||
| AI367724 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 5007 to 5297 | 330 to 40 | AAA | 291/292 (99 %) | 16 diff (94.6 %id) | ||
| BF740017 | Kidney | .a | 5030 to 5295 | 266 to 1 | 266/266 (100 %) | 0 diff (100 %id) | |||
| BI057002 | placenta_normal | .a | 5050 to 5300 | 1 to 250 | AAA | 250/292 (85 %) | 5 diff (98.3 %id) | ||
| DA820618 | pericardium | .a | 5053 to 5614 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
| FN060758 | breast carcinoma | .a | 5073 to 5155 | 83 to 1 | Submitted on the opposite strand | 83/83 (100 %) | 1 diff (98.8 %id) | ||
| D19746 | .a | 5080 to 5296 | 1 to 218 | Submitted on the opposite strand | 218/220 (99 %) | 4 diff (98.2 %id) | |||
| AI915664 | pooled | .a | 5086 to 5297 | 236 to 26 | AAA | 211/211 (100 %) | 4 diff (98.2 %id) | ||
| H87612 | placenta | .a | 5111 to 5439 | 1 to 331 | 331/337 (98 %) | 13 diff (96.2 %id) | |||
| DA061611 | cerebellum | .a | 5161 to 5726 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | ||
| DB249228 | uterus | .a | 5362 to 5835 | 2 to 477 | tiling clone, capped | 476/476 (100 %) | 2 diff (99.6 %id) | ||
| BE777890 | eye, retinoblastoma | .a | 5367 to 5944 | 1 to 578 | tiling clone, | 578/858 (67 %) | 21 diff (97.6 %id) | ||
| DW461898 | Liver | .a | 5454 to 5558 | 17 to 122 | 106/122 (86 %) | 6 diff (95.1 %id) | |||
| CK004066 | brain/CNS, Human Brain - Cerebellar Cortex | .a | 5617 to 5767 | 1 to 151 | 151/152 (99 %) | 2 diff (98.7 %id) | |||
| CN268441 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 5826 to 6364 | 1 to 539 | tiling clone, | 539/539 (100 %) | 1 diff (99.9 %id) | ||
| CU445929 | epidermis | .a | 5928 to 6516 | 605 to 17 | Submitted on the opposite strand | 589/605 (97 %) | 0 diff (100 %id) | ||
| BF373564 | prostate_tumor | .a | 6012 to 6312 | 308 to 5 | tiling clone, | 304/321 (94 %) | 0 diff (100 %id) | ||
| AA210974 | .a | 6185 to 6503 | 1 to 319 | 319/319 (100 %) | 17 diff (94.7 %id) | ||||
| BG166607 | hypernephroma, cell line, Kidney | .a | 6303 to 6979 | 1 to 683 | tiling clone, | 683/768 (88 %) | 28 diff (96.4 %id) | ||
| TI_151786372 | .a | 6569 to 7115 | 281 to 835 | tiling clone, | 555/1157 (47 %) | 24 diff (98.0 %id) | |||
| BM683548 | eye, fetal eye | .a | 6750 to 7399 | 668 to 19 | tiling clone, AAA | 650/656 (99 %) | 3 diff (99.6 %id) | ||
| DB351008 | uterus | .a | 6925 to 7403 | 480 to 1 | 480/480 (100 %) | 4 diff (99.2 %id) | |||
| BM927934 | hepatocellular carcinoma, cell line, Liver | .a | 6954 to 7411 | 28 to 484 | tiling clone, AAA | 457/484 (94 %) | 6 diff (98.8 %id) | ||
| AI804007 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .a | 6964 to 7399 | 439 to 4 | 436/440 (99 %) | 0 diff (100 %id) | |||
| AA211372 | .a | 6996 to 7402 | 407 to 1 | tiling clone, | 407/407 (100 %) | 0 diff (100 %id) | |||
| AA573625 | .a | 7063 to 7399 | 1 to 336 | 336/337 (99 %) | 4 diff (98.9 %id) | ||||
| T86707 | liver and spleen | .a | 7094 to 7389 | 300 to 1 | 300/338 (88 %) | 6 diff (98.3 %id) | |||
| BE673517 | Prostate | .a | 7109 to 7403 | 306 to 12 | AAA | 295/295 (100 %) | 3 diff (99.0 %id) | ||
| AW449911 | .a | 7135 to 7411 | 292 to 16 | AAA | 277/280 (98 %) | 5 diff (98.3 %id) | |||
| GD160463 | .a | 7173 to 7399 | 8 to 234 | AAA | 227/234 (97 %) | 6 diff (97.5 %id) | |||
| GD160482 | .a | 7173 to 7399 | 8 to 236 | AAA | 229/236 (97 %) | 6 diff (97.5 %id) | |||
| BG057167 | dorsal root ganglia | .a | 7221 to 7398 | 179 to 2 | 178/189 (94 %) | 0 diff (100 %id) | |||
| DB473277 | hippocampus | .b | 1 to 482 | 1 to 482 | tiling clone, | Submitted on the opposite strand | 482/482 (100 %) | 1 diff (99.8 %id) | |
| DB542050 | hippocampus | .b | 1496 to 1963 | 1 to 468 | tiling clone, | Submitted on the opposite strand | 468/468 (100 %) | 1 diff (99.8 %id) | |
| AK308757 | amygdala | .c | 1 to 2366 | 2 to 2367 | T348S Q361R | tiling clone, | 2367/2367 (100 %) | 3 diff (99.9 %id) | |
| CU449266 | epidermis | .c | 2220 to 2961 | 10 to 751 | tiling clone, | 742/761 (97 %) | 5 diff (99.4 %id) | ||
| CU451668 | epidermis | .c | 2220 to 2961 | 10 to 750 | 741/757 (97 %) | 7 diff (99.1 %id) | |||
| BM152650 | leukopheresis | .c | 2607 to 2802 | 1 to 196 | 196/200 (98 %) | 1 diff (99.5 %id) | |||
| EL594055 | epidermis, skin | .d | 1 to 782 | 13 to 786 | tiling clone, | 774/801 (96 %) | 24 diff (97.1 %id) | ||
| BU169445 | embryonal carcinoma, cell line, testis | .d | 470 to 1353 | 1 to 891 | tiling clone, | 891/891 (100 %) | 23 diff (97.5 %id) | ||
| BQ333134 | lung_tumor | .e | 1 to 222 | 228 to 6 | tiling clone, | 223/228 (97 %) | 0 diff (100 %id) | ||
| CB265331 | adipose | .e | 39 to 530 | 1 to 492 | tiling clone, | 492/492 (100 %) | 0 diff (100 %id) | ||
| BU633308 | cell lines, Chondrosarcoma | .e | 513 to 1221 | 727 to 19 | tiling clone, AAA | 709/709 (100 %) | 0 diff (100 %id) | ||
| BG219008 | .f | 1 to 578 | 587 to 4 | N2E R3P I4G C5F E6A ... | tiling clone, | Submitted on the opposite strand | 584/889 (65 %) | 26 diff (97.1 %id) | |
| BM556214 | duodenal adenocarcinoma, cell line, small intestine | .f | 491 to 1441 | 1 to 959 | tiling clone, | 959/1038 (92 %) | 14 diff (98.7 %id) | ||
| CN264863 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .f | 820 to 1132 | 1 to 313 | 313/322 (97 %) | 4 diff (98.8 %id) | |||
| DA925588 | small intestine | .f | 1170 to 1754 | 2 to 586 | tiling clone, capped | 585/585 (100 %) | 2 diff (99.7 %id) | ||
| DW462357 | Liver | .f | 1188 to 1547 | 10 to 369 | 360/369 (97 %) | 6 diff (98.4 %id) | |||
| DW465230 | Liver | .f | 1188 to 1537 | 10 to 359 | 350/359 (97 %) | 5 diff (98.7 %id) | |||
| AA652780 | .f | 1254 to 1548 | 8 to 302 | 295/302 (97 %) | 6 diff (98.1 %id) | ||||
| DB332121 | small intestine | .f | 2431 to 2968 | 538 to 1 | tiling clone, | 538/538 (100 %) | 11 diff (98.0 %id) | ||
| TI_154044860 | .g | 1 to 732 | 810 to 89 | H23R P75A | tiling clone, AAA | 722/909 (79 %) | 17 diff (98.2 %id) | ||
| AW197668 | Kidney | .g | 595 to 738 | 151 to 8 | tiling clone, | 144/151 (95 %) | 0 diff (100 %id) | ||
| AL708503 | human skeletal muscle | .h-u | 1 to 691 | 1 to 691 | exact | tiling clone, | 691/691 (100 %) | 1 diff (99.9 %id) | |
| BF946662 | nervous_normal | .h-u | 214 to 580 | 1 to 365 | tiling clone, | 365/365 (100 %) | 9 diff (97.6 %id) | ||
| BF950418 | nervous_normal | .h-u | 590 to 923 | 343 to 9 | tiling clone, | 335/343 (97 %) | 0 diff (100 %id) | ||
| BF946657 | nervous_normal | .h-u | 591 to 933 | 365 to 23 | tiling clone, | 343/365 (93 %) | 0 diff (100 %id) | ||
| BG033427 | breast, mammary adenocarcinoma, cell line | .i | 1 to 722 | 1 to 727 | C15V N16I L17S S18A T19L ... | tiling clone, | 722/911 (79 %) | 18 diff (98.1 %id) | |
| BU179770 | melanotic melanoma, cell line, skin | .i | 342 to 641 | 1 to 300 | V32W N34R S35T W36P T37G | 614/973 (63 %) | 25 diff (97.5 %id) | ||
| AW410349 | muscle, rhabdomyosarcoma | .i | 466 to 855 | 26 to 415 | exact | tiling clone, | 390/415 (93 %) | 8 diff (98.1 %id) | |
| BQ353817 | head_neck | .j | 1 to 518 | 1 to 522 | tiling clone, | 522/540 (96 %) | 11 diff (98.0 %id) | ||
| BM454231 | lymph, lymphoma, cell line | .j | 122 to 773 | 11 to 669 | H46S H47P V48C G49W Q50P ... | tiling clone, | 659/1094 (60 %) | 17 diff (98.5 %id) | |
| BF912901 | uterus_tumor | .k-u | 1 to 352 | 376 to 26 | exact | tiling clone, | Submitted on the opposite strand | 351/376 (93 %) | 0 diff (100 %id) |
| CV569294 | cornea, eye | .k-u | 65 to 654 | 1 to 590 | tiling clone, | 590/590 (100 %) | 0 diff (100 %id) | ||
| DA061660 | cerebellum | .l | 1 to 511 | 2 to 512 | exact | tiling clone, capped | 511/511 (100 %) | 0 diff (100 %id) | |
| AW367445 | head_neck | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AW376916 | colon | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| AW376988 | colon | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| AW376989 | colon | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BC032665 | Lymph, lymphoma | Gene EEF2K, variant not shown | available from MGC, AAA | Suspected internal deletion, this clone was ignored | |||||
| BX107799 | eye, retina | Gene EEF2K, variant not shown | AAA | This clone was ignored | |||||
| AU279717 | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | |||||||
| BX451794 | neuroblastoma | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| BX451795 | neuroblastoma | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| BX360561 | Placenta Cot 25-normalized | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BX360562 | Placenta Cot 25-normalized | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BX341520 | Gene EEF2K, variant not shown | This clone was ignored | |||||||
| BX362572 | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | |||||||
| CU446296 | epidermis | Gene EEF2K, variant not shown | Submitted on the opposite strand | ||||||
| CU448142 | epidermis | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BP243068 | Liver | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| H30037 | eye, retina | Gene EEF2K, variant not shown | fully sequenced, | This clone was ignored | |||||
| H30038 | eye, retina | Gene EEF2K, variant not shown | fully sequenced, | This clone was ignored | |||||
| W67721 | heart | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| W94803 | heart | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AA777538 | liver and spleen | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AI333526 | lung | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| BG178258 | adenocarcinoma, cell line, Prostate | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BG532716 | embryonal carcinoma, testis | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| BM469975 | lymph, lymphoma, cell line | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BQ686526 | ductal carcinoma, cell line, Pancreas | Gene EEF2K, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BQ706210 | Spleen | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| CB156101 | Liver | Gene EEF2K, variant not shown | This clone was ignored | ||||||
| DB368251 | Gene EEF2K, variant not shown | This clone was ignored | |||||||
| DA735877 | Gene EEF2K, variant not shown | capped | This clone was ignored | ||||||
| BM837534 | Ascites, stomach | Gene EEF2K, variant not shown | Suspected internal deletion, suspected internal deletion, this clone was ignored |